For more than a decade, Pennsylvania’s Commonwealth Universal Research Enhancement Program (CURE) has supported a broad range of biomedical research at 39 institutions across Pennsylvania. These funds have led to research advances in cancer, cardiovascular disease, diabetes, infectious diseases, and other health areas and improvements in public health.
In his budget for fiscal year 2013, Governor Corbett proposes defunding the CURE program created by Act 77 in 2001, diverting almost $60 million in research funds from the tobacco settlement into the general budget for other purposes. If the defunding takes place, Jefferson stands to lose $2 to $4 million per year in research funding.
Left intact with sustained funding, the CURE program will advance promising medical discoveries, support the hiring and retention of skilled workers, leverage federal and private research funding, and catalyze the formation of biotechnology companies.
Please voice your support of the CURE program by taking a moment to send a note (see suggested letter HERE) to your PA State representative. You can find your representative on this website. Jefferson’s Kimmel Cancer Center is a member of the Pennsylvania Cancer Alliance.
Contact for questions or further information:
Thomas Jefferson University
Thomas Jefferson University Hospitals
211 South 9th Street
Suite 300, Walnut Towers
Philadelphia, PA 19107